Therapeutic Targets in Pancreatic Cancer: 2nd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 37
Special Issue Editors
Interests: radiooncology; translational research; clinical trials; pancreatic cancer; supportive therapy
Special Issues, Collections and Topics in MDPI journals
Interests: pancreatic cancer; translational research; therapeutic targets and novel interventional strategies; mechanisms of anti-tumor reactions; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: radiotherapy; immunotherapy; vaccination; immune checkpoints; hyperthermia; tumor immunology; immunogenic cancer cell death; immunomonitoring; inflammatory and degenerative diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As the Guest Editors of this Special Issue, we would like to welcome contributions from various topics and different viewpoints on this research area.
In this Special Issue, we aim to cover all aspects of the current landscape of translational research in pancreatic cancer: prognostic and predictive biomarkers, molecular targeting, DNA damage and repair, targeted and immune therapies, and mechanisms of tumor defense.
Translational and basic approaches are welcome; immunological aspects in the pre-clinic as well as in the patient are desirable. Genetic approaches in prospective patient cohorts (e.g., within the ongoing clinical trials), which are translationally obtained, and the molecular characterization of tumor tissue for better treatment selection are also of interest.
We would like to gain insight into new preclinical strategies for the treatment of pancreatic cancer, especially new targets for therapy or the avoidance of resistance to radiation and/or chemotherapy. Pure evaluations of existing cohorts are only accepted in exceptional cases. A translational approach should always be recognizable.
We are looking forward to receiving your submission.
Dr. Dorota Lubgan
Dr. Nathalie Britzen-Laurent
Dr. Benjamin Frey
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- translational research
- therapeutic targets and novel interventional strategies
- mechanisms of anti-tumor reactions
- biomarkers
